Small molecule CD4 mimetics and uses thereof
The invention provides for compounds of formula I: wherein Z is absent or (CR A R B ) n W; each RA and RB is independently (i) H, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, haloalkyl, each of which may be optionally substituted; (ii) OH, ORc, NH2, NHR c , NR c R c , SH, S(O) m R c ; or (iii) R A and R B together form C(O); W is absent, C(O), C(O)O, C(O)NR c R c , O, S(O) m , or NR c R c ; Y is an optionally substituted heterocyclic, optionally substituted heteroaryl, optionally substituted cycloalkyl, optionally substituted aryl, or NR X R Y ; wherein R x and R y are each independently H, alkyl or aryl; X 1 is selected from the group consisting of halogen, methyl, and hydroxyl; X2 is a halogen; each R c is independently alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl, each of which may be optionally substituted; m is O, 1, or 2; and n is 1, 2, 3, 4, 5, or 6; and pharmaceutically acceptable salts thereof.
1. A compound of formula I:
wherein:
Z is absent;
Y is optionally substituted cycloalkyl or optionally substituted aryl;
X 1 is fluorine;
X 2 is halogen;
or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 , wherein Y is cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, [3.3.0]bicyclooctane, [4.3.0]bicyclononane, [4.4.0]bicyclodecane, [2.2.2]bicyclooctane, fluorenyl, phenyl, naphthyl, indanyl, or tetrahydronaphthyl, each of which may be optionally substituted.
3. The compound of claim 1 , wherein Y is:
each of which may be optionally substituted.
4. The compound of claim 1 , that is:
or a pharmaceutically acceptable salt thereof.
5. The compound of claim 1 , that is:
or a pharmaceutically acceptable salt thereof.
6. The compound of claim 1 that is:
7. The compound of claim 1 that is
or a pharmaceutically acceptable salt thereof.
8. The compound of claim 1 , that is: